Aerobic And Resistance Exercise In Late-Onset Pompe Disease Treated With Enzymatic Replacement Therapy: A Systematic Review

نویسندگان

  • Sergio Jiménez Morgan
  • José Arturo Molina Mora
چکیده

Purpose: to systematically review the current evidence on the effects of aerobic and resistance exercise in lateonset Pompe disease patients treated with enzymatic replacement therapy. Methods: a systematic search of the literature was conducted on Academic Search Complete, Medline with full text, SPORTDiscus, Pubmed, and Science Direct electronic databases. In addition, cross-referencing and manual search of printed journals was performed. The eligibility criteria were (a) experimental or quasiexperimental research design; (b) intervention with aerobic exercise, resistance exercise, or both; (c) published studies until August 2016; (d) studies published in English, Spanish, French or Portuguese; (e) studies on human beings. This systematic review was reported in accordance with the PRISMA statement. Results: of the 166 citations identified, 4 met the eligibility criteria and were included in the review. All studies had a small sample size, and ranged from 5 to 23 participants. In three of the studies, the training programs allowed subjects to improve physical parameters like muscular strength, endurance, core stability, and to decrease pain and fatigue. Overall, body composition remained unchanged. Conclusions: the results found in this review suggest that aerobic and resistance training may be beneficial in this population. There is a need for additional, larger sample sizes, longer studies with more homogeneous training programs on this topic.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Effects of Aerobic Exercise Training in Late-Onset Pompe Disease Before and 1 Month after Enzyme Replacement Therapy.

Pompe disease is a progressive multisystem disease caused by a lysosomal acid α-glycosidase enzyme (GAA) defi ciency, resulting in lysosomal accumulation of glycogen. The late-onset form is characterized by progressive skeletal and respiratory muscle dysfunction leading to functional disability and impairment of quality of life. Enzyme replacement therapy (ERT) and treatments, such as protein-e...

متن کامل

Late-onset Pompe Disease with Elevated Liver Transaminases: A Case Report

Pompe disease or type II glycogen storage disease is a rare autosomal hereditary disease. The prevalence of the disease is about 1 in 40,000 to 1 in 300,000 population. It usually occurs as a result of glycogen accretion following acid maltase deficiency. The current treatment is enzyme replacement therapy, which may slow down the disease progression. Sometimes, the clinical presentation can be...

متن کامل

A New Mutation Causing Severe Infantile-Onset Pompe Disease Responsive to Enzyme Replacement Therapy

Pompe disease (PD), also known as “glycogen storage disease type II (OMIM # 232300)” is a rare autosomal recessive disorder characterized by progressive glycogen accumulation in cellular lysosomes. It ultimately leads to cellular damage. Infantile-onset Pompe disease (IOPD) is the most severe type of this disease and is characterized by severe hypertrophic cardiomyopathy and generalized hypoton...

متن کامل

P181: Effect of Aquatic Therapy on Improvement of Patients with Parkinson Disease: A Systematic Review

Parkinson disease (PD) is a degenerative neurological disorder that affects 0.5- 1% of old people in western countries. It primarily affects mobility function, and associated with increasing disability over time. People with PD express bradykinesia, rigidity, tremor, progressive postural instability and muscle weakness as symptoms of PD. Various exercise programs, including resistance or aerobi...

متن کامل

Consensus treatment recommendations for late-onset Pompe disease.

INTRODUCTION Pompe disease is a rare, autosomal recessive disorder caused by deficiency of the glycogen-degrading lysosomal enzyme acid alpha-glucosidase. Late-onset Pompe disease is a multisystem condition, with a heterogeneous clinical presentation that mimics other neuromuscular disorders. METHODS Objective is to propose consensus-based treatment and management recommendations for late-ons...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2016